Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011;16(8):1070-1.
doi: 10.1634/theoncologist.2011-0167. Epub 2011 Jul 17.

Quality of life and targeted treatment for metastatic renal cell carcinoma

Martin Stockler  1
Affiliations
Comment

Quality of life and targeted treatment for metastatic renal cell carcinoma

Martin Stockler. Oncologist. 2011.

Abstract

The results of quality of life analyses from a randomized, placebo-controlled phase III trial of everolimus for metastatic renal cell carcinoma patients progressing after treatment with sunitinib or sorafenib are reviewed.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Martin Stockler: None.

The content of this article has been reviewed by independent peer reviewers to ensure that it is balanced, objective, and free from commercial bias. No financial relationships relevant to the content of this article have been disclosed by the author or independent peer reviewers.

Comment on

References

    1. Beaumont JL, Butt Z, Baladi J, et al. Patient-reported outcomes in a phase III study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy. The Oncologist. 2011;16:632–640. - PMC - PubMed
    1. Motzer RJ, Escudier B, Oudard S, et al. Efficacy of everolimus in advanced renal cell carcinoma: A double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008;372:449–456. - PubMed
    1. Cella D, Yount S, Brucker PS, et al. Development and validation of a scale to measure disease-related symptoms of kidney cancer. Value Health. 2007;10:285–293. - PubMed
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. - PubMed

MeSH terms

Substances